176 related articles for article (PubMed ID: 5669210)
21. The differential response to parenteral chlorpromazine and mesoridazine in psychotic patients.
Brauzer B; Goldstein BJ
J Clin Pharmacol J New Drugs; 1970; 10(2):126-31. PubMed ID: 4906541
[No Abstract] [Full Text] [Related]
22. Psychopharmacology and psychopathology.
Cole JO
Proc Annu Meet Am Psychopathol Assoc; 1969; 58():253-65. PubMed ID: 4898738
[No Abstract] [Full Text] [Related]
23. Comparison of the therapeutic results of clothiapin and perphenazine in schizophrenia.
Rodová A; Náhunek K; Svestka J
Act Nerv Super (Praha); 1971; 13(3):171-3. PubMed ID: 4939829
[No Abstract] [Full Text] [Related]
24. Schizophrenia as a disorder of neuro-psychological control mechanisms.
Dussik KT
Dis Nerv Syst; 1968 May; 29(5):Suppl:68-77. PubMed ID: 5673626
[No Abstract] [Full Text] [Related]
25. [ECG picture in the course of treatment of schizophrenia with phenothiazine derivatives].
Welbel L; Zalewski K
Psychiatr Pol; 1971; 5(1):49-54. PubMed ID: 5551991
[No Abstract] [Full Text] [Related]
26. [Lyogen therapy of outcome states in schizophrenia with catatonic symptoms].
Gorskiĭ GD; Rybakov VL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(10):1575-8. PubMed ID: 5490155
[No Abstract] [Full Text] [Related]
27. [Experience with the butyrophenone preparation Luvatren in the therapy of schizophrenia].
Weiser G
Wien Med Wochenschr; 1968 May; 118(19):444-6. PubMed ID: 5702494
[No Abstract] [Full Text] [Related]
28. [Attempt of evaluation of the late effects of majeptil therapy].
Maksimowska M
Psychiatr Pol; 1967; 1(3):301-5. PubMed ID: 4385756
[No Abstract] [Full Text] [Related]
29. [Proketazine in the treatment of psychotic syndromes].
Klosińska B; Wierzbicki T
Psychiatr Pol; 1967; 1(1):69-71. PubMed ID: 5597274
[No Abstract] [Full Text] [Related]
30. [A polygraphic study of sleep in schizophrenics].
Azumi K
Seishin Shinkeigaku Zasshi; 1966 Oct; 68(10):1222-41. PubMed ID: 6009631
[No Abstract] [Full Text] [Related]
31. The effectiveness of combined phenothiazine and butyrophenone treatment in chronic schizophrenic patients.
Lehmann HE; Ban TA; Lee H
Curr Ther Res Clin Exp; 1967 Jan; 9(1):36-7. PubMed ID: 4963021
[No Abstract] [Full Text] [Related]
32. [Comparative effectiveness of various correctors of the neurologic side effects of neruoleptic drugs].
Magalif AIu
Zh Nevropatol Psikhiatr Im S S Korsakova; 1968; 68(9):1381-7. PubMed ID: 5700611
[No Abstract] [Full Text] [Related]
33. Antipsychotic properties of loxapine succinate.
Gershon S; Hekimian LJ; Burdock EI; Kim SS
Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243
[No Abstract] [Full Text] [Related]
34. Sleep electroencephalographic and eye-movement patterns in patients with schizophrenia and with chronic brain syndrome.
Feinberg I
Res Publ Assoc Res Nerv Ment Dis; 1967; 45():211-40. PubMed ID: 6083192
[No Abstract] [Full Text] [Related]
35. Somnambulism: all-night EEG and related studies.
Jacobson A; Kales A
Res Publ Assoc Res Nerv Ment Dis; 1967; 45():424-55. PubMed ID: 5584130
[No Abstract] [Full Text] [Related]
36. [Hallucinatory paraphrenic syndrome in the course of schizophrenia].
Petrova ES
Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(9):1384-91. PubMed ID: 4386459
[No Abstract] [Full Text] [Related]
37. [Management of chronic schizophrenias using Valium].
Baliarda A
Schweiz Arch Neurol Neurochir Psychiatr; 1969; 104(1):109-22. PubMed ID: 5801167
[No Abstract] [Full Text] [Related]
38. Drug effects on auditory attention in paranoid and nonparanoid schizophrenics.
Rappaport M; Hopkins HK
J Nerv Ment Dis; 1969 Jun; 148(6):597-605. PubMed ID: 5772724
[No Abstract] [Full Text] [Related]
39. [Transitory exacerbations arising during the course of neuroleptic therapy].
Gurovich IIa
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970; 70(6):919-25. PubMed ID: 5471621
[No Abstract] [Full Text] [Related]
40. Differences in therapeutic effects of phenothiazine drugs.
Vinar O
Agressologie; 1968; 9(2):315-7. PubMed ID: 4877493
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
